Misoprostol
NDC Package 42571-253-12

11-digit billing NDC: 42571025312

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Misoprostol is  tablets are indicated for reducing the risk of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. Marketed by Micro Labs Limited, this product is identified by NDC 42571-253 and is authorized under FDA application ANDA216872.

Identification & Billing

NDC Package Code
42571-253-12
Package Description
120 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
42571025312

Clinical Specifications

Proprietary Name
Misoprostol
Dosage Form
-
Usage Information
Misoprostol tablets are indicated for reducing the risk of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.  Misoprostol tablets has not been shown to reduce the risk of duodenal ulcers in patients taking NSAIDs.  Misoprostol tablets should be taken for the duration of NSAID therapy.  Misoprostol tablets has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months’ duration. It had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with NSAID use.

Regulatory & Marketing

Labeler Name
Micro Labs Limited
FDA Application #
ANDA216872
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-01-2023
End Marketing Date
08-05-2026
Listing Expiration
08-05-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42571-253). Click a package code to view its specific billing and regulatory data.

60 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42571-253-12 identifies a specific commercial package of 120 tablet in 1 bottle of Misoprostol, labeled by Micro Labs Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Micro Labs Limited on January 01, 2023. The current certification is valid through August 05, 2026.

How is this Micro Labs Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42571025312. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42571-253-12
11-Digit CMS (5-4-2)
42571-0253-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.